Glaukos

IPO

Advancing the Treatment of Ophthalmic Diseases

Public · Aliso Viejo, United States · Founded 1998 · $30.0M raised

Employees
1001–5000
Founded
1998
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series FJan 2013
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Global ophthalmic medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases.

Summary

Glaukos is a Healthcare company based in Aliso Viejo, United States, founded in 1998. It has raised $30.0M in total across 1 round, most recently a $30.0M Series F round in Jan 2013. Investors include Montreux Equity Partners, Versant Ventures and Meritech Capital Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2015
$140.0M

Sign up to see all 2 events

Funding: Series F. Amounts, valuations, and investors where available.

Investors

Similar Companies

PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Glaukos on Indexed.vc
<a href="https://indexed.vc/companies/glaukos"><img src="https://indexed.vc/api/badge/company/glaukos" alt="Glaukos on Indexed.vc" width="260" height="76" /></a>